Skip to main content
Premium Trial:

Request an Annual Quote

Tessella to Add Definiens Software to IT Services

Tessella plans to integrate Definiens' XD image-analysis software with the IT infrastructure of pharmaceutical and biotech companies.

NEW YORK (GenomeWeb News) — IT and consulting company Tessella has signed a systems integration partnership with Definiens under which it will implement the company's Definiens' XD image-analysis software at pharmaceutical and biotech companies.

Definiens, based in Munich, Germany, said today that Tessella also will independently market software that integrates the Defniens Cognition Network Technology, which is used to extract information from images.

"The partnership will expand our access to new markets and allow us to pursue larger clients for our premiere imaging-analysis technology," Manfred Voglmaier, Definiens' vice president of business development, said in a statement.

Financial terms of the deal were not disclosed.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.